Multicenter Study to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP) (C-MAP)

May 18, 2023 updated by: Dr. Nusrat Husain, Pakistan Institute of Living and Learning

Multicenter RCT to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP) in Patients With a History of Self-harm

To evaluate the clinical and cost-effectiveness of a culturally adapted therapy (C-MAP) in patients with a history of self-harm

Study Overview

Status

Completed

Conditions

Detailed Description

Suicide is a serious global public health issue, ranked amongst the leading causes of death in many countries. Most of these (75%) are in the low and middle income countries (LAMIC) and globally suicide is the second leading cause of death in young people 15-29 years of age. There is no official data on suicide from Pakistan, a conservative South Asian Islamic country with historically low suicide rates. Both suicide and attempted suicide are illegal acts, as well as socially and religiously condemned, however, there is accumulating evidence that suicide rates have been gradually increasing in Pakistan over the last few years.

The culturally adapted psychological intervention C-MAP utilizes problem solving components within a brief intervention that can be widely utilized in clinical practice. Our previous pilot trial in Karachi shows the efficacy of CBT based intervention(C-MAP) in people who had recently self harmed.The findings from this work have highlighted the applicability of such an intervention to health services in Pakistan for patients who present after a self-harm episode

Study Type

Interventional

Enrollment (Actual)

901

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Balochistan
      • Quetta, Balochistan, Pakistan
        • Bolan Medical Complex
    • KPK
      • Peshawar, KPK, Pakistan
        • Khyber Teaching Hospital
    • Punjab
      • Lahore, Punjab, Pakistan
        • Services Hospital
      • Lahore, Punjab, Pakistan
        • Jinah Hospital
      • Rawalpindi, Punjab, Pakistan
        • Rawalpindi General Hospital
    • Sind
      • Karachi, Sind, Pakistan, 72400
        • Civil Hospital
    • Sindh
      • Karachi, Sindh, Pakistan
        • Abbasi Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients over the age of 18 years will be considered eligible for the study.
  2. Participants will have to be living within the catchment area of the participating practices and hospitals.
  3. Not needing inpatient psychiatric treatment.

Exclusion Criteria:

  1. Temporary resident unlikely to be available for follow up.
  2. Participants with ICD-I0 mental disorder; due to a general medical condition or substance misuse, dementia, delirium, alcohol or drug dependence, schizophrenia, bipolar disorder, learning disability.
  3. Unable to engage, participate or respond to the research questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Culturally adapted therapy (C-MAP)
Culturally adapted manual assisted (C-MAP) brief problem solving therapy
C-MAP is a brief problem focused therapy, comprising of six sessions delivered within three months. C-MAP is a manual assisted intervention based on the principles of CBT .In this intervention there is an evaluation of the self-harm attempt, crisis skills, problem solving and basic cognitive techniques to manage emotions, negative thinking and relapse prevention strategies.
Other Names:
  • psycho social intervention
No Intervention: Treatment as usual
This arm will receive no intervention only TAٓU.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Suicide Attempt Self Injury Interview SASII
Time Frame: up to 12th months
Repetition rate of self-harm measured by adapted Suicide Attempt Self-Injury Interview (SASII)
up to 12th months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Scale for Suicidal ideation (BSI).
Time Frame: Baseline, 3, 6, 9 and 12th months
This is a 19-item instrument for detecting and measuring the current intensity of the patients' specific attitudes, behaviours, and specificity of a patient's thoughts to kill him/herself during the past week.
Baseline, 3, 6, 9 and 12th months
Beck Hopelessness Scale
Time Frame: Baseline,3rd,6th,9th and 12th months
This is a 21 items scale measuring symptoms of depression. Higher scores on the scale indicate greater severity of depression
Baseline,3rd,6th,9th and 12th months
Beck Depression Inventory (BDI)
Time Frame: Baseline,3rd,6th,9th and 12th months
This is a 21 items scale measuring symptoms of depression. Higher scores on the scale indicate greater severity of depression
Baseline,3rd,6th,9th and 12th months
EuroQol-5 Dimensions (EQ5-D)
Time Frame: Baseline,3rd,6th,9th and 12th months
A standardised instrument to measure health status and associated population utility weights. It consists of a self-report questionnaire covering five dimensions of health (mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression).
Baseline,3rd,6th,9th and 12th months
Coping Resource Inventory (CRI).
Time Frame: Baseline,3rd,6th,9th and 12th months
To assess the coping resources to manage stress available to an individual.
Baseline,3rd,6th,9th and 12th months
Client Satisfaction Questionnaire (CSQ).
Time Frame: Baseline,3rd,6th,9th and 12th months
The participants will rate their satisfaction with treatment by using the CSQ.
Baseline,3rd,6th,9th and 12th months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 27, 2016

Primary Completion (Actual)

July 30, 2019

Study Completion (Actual)

October 30, 2019

Study Registration Dates

First Submitted

February 19, 2016

First Submitted That Met QC Criteria

April 18, 2016

First Posted (Estimate)

April 19, 2016

Study Record Updates

Last Update Posted (Actual)

May 19, 2023

Last Update Submitted That Met QC Criteria

May 18, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe